Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Virology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17135326PMCID PMC1797564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.

  2006cited by this paper
• Lipid phosphatases as drug discovery targets for type 2 diabetes

  2006cited by this paper
• Reactive oxygen species have a causal role in multiple forms of insulin resistance

  2006cited by this paper
• Molecular Determinants for Subcellular Localization of Hepatitis C Virus Core Protein

  2005cited by this paper
• Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.

  2005cited by this paper
• Hepatitis C Virus Core Protein Inhibits Mitochondrial Electron Transport and Increases Reactive Oxygen Species (ROS) Production*

  2005cited by this paper
• Intramembrane Proteolysis and Endoplasmic Reticulum Retention of Hepatitis C Virus Core Protein

  2004cited by this paper
• Membrane Binding Properties and Terminal Residues of the Mature Hepatitis C Virus Capsid Protein in Insect Cells

  2004cited by this paper
• SREBPs suppress IRS-2-mediated insulin signalling in the liver

  2004cited by this paper
• Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

  2004cited by this paper
• Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.

  2003cited by this paper
• Ultrastructural evidences of HCV infection in hepatocytes of chronically HCV-infected patients.

  2003cited by this paper
• Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein.

  2002cited by this paper
• Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle*

  2002cited by this paper
• Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

  2002cited by this paper
• Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets

  2002cited by this paper
• Genomic analysis of the host response to hepatitis C virus infection

  2002cited by this paper
• A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1

  2001cited by this paper
• Regulation of Insulin/Insulin-like Growth Factor-1 Signaling by Proteasome-mediated Degradation of Insulin Receptor Substrate-2*

  2001cited by this paper
• Clinical review 125: The insulin receptor and its cellular targets.

  2001cited by this paper
• A Critical Role for the Proteasome Activator PA28 in the Hsp90-dependent Protein Refolding*

  2000cited by this paper
• The PI3K-PDK1 connection: more than just a road to PKB.

  2000cited by this paper
• Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.

  2000cited by this paper
• Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.

  2000cited by this paper
• Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway.

  1999cited by this paper
• Further evidence for an association between non–insulin‐dependent diabetes mellitus and chronic hepatitis C virus infection

  1999cited by this paper
• Interaction of Hepatitis C Virus Core Protein with Viral Sense RNA and Suppression of Its Translation

  1999cited by this paper
• Growth retardation in mice lacking the proteasome activator PA28gamma.

  1999cited by this paper
• Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide.

  1999cited by this paper
• Association of diabetes mellitus and chronic hepatitis C virus infection

  1999cited by this paper
• The role of TNFalpha and TNF receptors in obesity and insulin resistance.

  1999cited by this paper
• Development of a Simple and Highly Sensitive Enzyme Immunoassay for Hepatitis C Virus Core Antigen

  1999cited by this paper
• Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection

  1998cited by this paper
• Disruption of IRS-2 causes type 2 diabetes in mice

  1998cited by this paper
• Type 2 Diabetes: When Insulin Secretion Fails to Compensate for Insulin Resistance

  1998cited by this paper
• Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.

  1998cited by this paper
• Altered Expression Levels and Impaired Steps in the Pathway to Phosphatidylinositol 3-Kinase Activation via Insulin Receptor Substrates 1 and 2 in Zucker Fatty Rats

  1998cited by this paper
• The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

  1998cited by this paper
• Full‐length complementary DNA of hepatitis C virus genome from an infectious blood sample

  1998cited by this paper
• The IRS-signalling system: A network of docking proteins that mediate insulin action

  1998cited by this paper
• Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

  1997cited by this paper
• Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection.

  1997cited by this paper
• Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse.

  1997cited by this paper
• Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.

  1997cited by this paper
• Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations

  1995cited by this paper
• Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population.

  1994cited by this paper
• Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1

  1994cited by this paper
• Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene

  1994cited by this paper
• Sequence analysis of the core gene of 14 hepatitis C virus genotypes.

  1994cited by this paper
• Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites

  1993cited by this paper
• Genetic organization and diversity of the hepatitis C virus.

  1991cited by this paper
• Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease

  1991cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector.

  1991cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

  1990cited by this paper
• Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

  1990cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper

• HCV infection activates the proteasome via PA28γ acetylation and heptamerization to facilitate the degradation of RNF2, a catalytic component of polycomb repressive complex 1

  2024cites this paper
• Unraveling the mechanisms of hepatogenous diabetes and its therapeutic perspectives.

  2024cites this paper
• Metabolic dysfunction and cancer in HCV: shared pathways and mutual interactions.

  2022cites this paper
• Metabolic complications of hepatitis C virus infection

  2021cites this paper
• Frequency and genotype distribution of hepatitis C virus infection in patients with diabetes type 2 in Ahvaz, Iran

  2021cites this paper
• Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond

  2021cites this paper
• The Proteasome System in Health and Disease.

  2020cites this paper
• Reciprocal REGγ-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma

  2020cites this paper
• A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress

  2020cites this paper
• Exploring the proteasome system: A novel concept of proteasome inhibition and regulation.

  2020cites this paper
• The Oncogenic Role of Hepatitis C Virus.

  2020cites this paper
• Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism

  2019cites this paper
• Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review

  2019cites this paper
• The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C

  2018cites this paper
• Hepatitis C virus clearance by direct‐acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients

  2018cites this paper
• Hepatitis C virus infection causes apoptosis and pyroptosis in both infected and bystander cells

  2017cites this paper
• The potential of signal peptide peptidase as a therapeutic target for hepatitis C

  2017cites this paper
• Hepatitis C virus core activates proteasomal activator 28γ expression via upregulation of p53 levels to control virus propagation.

  2017cites this paper
• Mechanism of Hepatitis C Virus-Induced Diabetes Mellitus.

  2017cites this paper
• Viral hepatitis and liver cancer

  2017cites this paper
• Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice

  2017cites this paper
• Metabolic Manifestations of Hepatitis C Virus: Diabetes Mellitus, Dyslipidemia.

  2017cites this paper
• Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?

  2017cites this paper
• Hepatitis C eradication with sofosbuvir leads to significant metabolic changes

  2016cites this paper
• Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus

  2016cites this paper
• Extrahepatic Manifestations of Chronic Hepatitis C Infection: a Review and Update

  2016cites this paper
• Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma.

  2016cites this paper
• Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation‐wide cohort study

  2015cites this paper
• Hepatitis C virus-induced glucose metabolic disorder.

  2015cites this paper
• Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosis.

  2015cites this paper
• Insulin resistance and its consequences in chronic hepatitis C

  2015influential citation
• Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis.

  2015cites this paper
• A novel transcript variant of proteasome activator 28γ: Identification and function in oral cancer cells.

  2015cites this paper
• Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma

  2015cites this paper
• Influence of host resistance on viral adaptation: hepatitis C virus as a case study

  2015cites this paper
• Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

  2014cites this paper
• Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

  2014cites this paper
• An association of virus infection with type 2 diabetes and Alzheimer's disease.

  2014cites this paper
• Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines

  2014cites this paper
• The oncogenic role of hepatitis C virus.

  2014cites this paper
• Interaction between hepatitis C virus and metabolic factors.

  2014cites this paper
• Production and pathogenicity of hepatitis C virus core gene products.

  2014cites this paper
• Inhibition of silent information regulator 1 induces glucose metabolism disorders of hepatocytes and enhances hepatitis C virus replication

  2013cites this paper
• Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia–Pacific region

  2013cites this paper
• Diabetes and Risk of Cancer

  2013cites this paper
• Hepatitis C Virus: From Molecular Virology to Antiviral Therapy

  2013cites this paper
• Amino Acid Substitutions in the Core Region Associate with Insulin Resistance in Chronic Hepatitis C

  2013cites this paper
• Understanding the biological context of NS5A-host interactions in HCV infection: a network-based approach.

  2013cites this paper
• Hepatitis C Virus and Hepatocellular Carcinoma

  2013cites this paper
• Hepatitis C virus nonstructural protein 5A favors upregulation of gluconeogenic and lipogenic gene expression leading towards insulin resistance: a metabolic syndrome

  2013cites this paper
• Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studies

  2012cites this paper
• The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.

  2012cites this paper
• Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

  2012cites this paper
• Inauspicious contribution of hepatitis C virus and diabetes mellitus targeting kidneys: an update.

  2012cites this paper
• Molecular Mechanism of Hepatitis C Virus-Induced Glucose Metabolic Disorders

  2012influential citation
• The interaction of metabolic factors with HCV infection: does it matter?

  2012influential citation
• [Chronic hepatitis C and insulin resistance].

  2012cites this paper
• Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta‐analysis of cohort studies

  2012cites this paper
• Fuzziness in the core of the human pathogenic viruses HCV and HIV.

  2012cites this paper
• Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

  2012cites this paper
• Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha‐2a plus ribavirin

  2012cites this paper
• Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study.

  2012cites this paper
• Roles of the two distinct proteasome pathways in hepatitis C virus infection.

  2012cites this paper
• The ubiquitin‐proteasome system in positive‐strand RNA virus infection

  2012cites this paper
• The ubiquitin-prote strand RNA virus

  2012cites this paper
• Association of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital-Based Case-Control Study

  2012cites this paper
• Impact of HCV genetic differences on pathobiology of disease

  2011cites this paper
• Cholesterol and chronic hepatitis C virus infection

  2011cites this paper
• Current understanding of insulin resistance in hepatitis C

  2011cites this paper
• echanisms of hepatitis C virus-related insulin esistance

  2011cites this paper
• Hepatitis C virus, oxidative stress and steatosis: current status and perspectives.

  2011cites this paper
• Insulin Resistance in Liver Diseases

  2011influential citation
• [Chronic hepatitis C, steatosis and insulin resistance--clinical implications].

  2011cites this paper
• Insulin resistance and hepatitis C: an evolving story

  2011cites this paper
• Hepatitis C Virus Infection: Molecular Pathways to Insulin resistance

  2011cites this paper
• Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3

  2011cites this paper
• Factors Causing IR in Liver Diseases Steatosis

  2011influential citation
• Animal models in the study of hepatitis C virus-associated liver pathologies

  2011cites this paper
• Hepatitis C Virus Infection Promotes Hepatic Gluconeogenesis through an NS 5 A-Mediated , FoxO 1-Dependent Pathway

  2011cites this paper
• Hepatitis C Virus Infection Promotes Hepatic Gluconeogenesis through an NS5A-Mediated, FoxO1-Dependent Pathway

  2011cites this paper
• Impact of Preexisting Diabetes Mellitus on Outcome After Liver Transplantation in Patients with Hepatitis B Virus-Related Liver Disease

  2011cites this paper
• Mechanisms of hepatitis C virus-related insulin resistance.

  2011cites this paper
• Role of the ubiquitin/proteasome system in coxsackievirus induced-myocarditis

  2010cites this paper
• Proteasome Activator REGγ Enhances Coxsackieviral Infection by Facilitating p53 Degradation

  2010cites this paper
• Network based analysis of hepatitis C virus core and NS4B protein interactions.

  2010cites this paper
• Oncogenic Potential of Hepatitis C Virus Proteins

  2010cites this paper
• Involvement of PA28γ in the propagation of hepatitis C virus

  2010cites this paper
• Animal models for hepatitis C and related liver disease

  2010cites this paper
• The importance of steatosis in chronic hepatitis C infection and its management: A review

  2010cites this paper
• Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data

  2009cites this paper
• HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.

  2009cites this paper
• Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.

  2009cites this paper
• Molecular mechanisms of insulin resistance in chronic hepatitis C.

  2009cites this paper
• “Second Hit” Models of Alcoholic Liver Disease

  2009cites this paper
• TOPIC HIGHLIGHT

  2009cites this paper
• Hepatitis C and diabetes: the inevitable coincidence?

  2009cites this paper
• Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance.

  2009cites this paper
• Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection

  2009cites this paper
• Molecular Mechanisms of Hepatitis C Virus- Associated Steatosis

  2009influential citation
• Insulin resistance and hepatitis C virus: a case–control study of non‐obese, non‐alcoholic and non‐steatotic hepatitis virus carriers with persistently normal serum aminotransferase

  2008cites this paper